We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
01 April 2020
The Federal Department of Home Affairs has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of blood and lymph gland cancer will in future be covered by compulsory healthcare insurance.
Further, preventive investigations of colorectal cancer will be exempted from the franchise in the Cantons of Fribourg and Basel-Stadt.
In addition to these changes, a number of other adaptations have been made to the Healthcare Benefits Ordinance (SR 832.112.31) and its annexes. All amendments to the ordinance entered into force on 1 January 2020.(1)
For further information on this topic please contact Andreas Wildi at Walder Wyss by telephone (+41 58 658 20 00) or email (email@example.com). The Walder Wyss website can be accessed at www.walderwyss.com.
(1) For further details please see here.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.